Lin Zhu

Prof. Lin Zhu

Guangzhou Sport University, Guangzhou, Guangdong, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2022 in Carbohydrate Polymers
Verified
Journal Article
Closed access
LHLin Huang
Lin Huang
WLWenqiang Li
Wenqiang Li
MGMingtao Guo
Mingtao Guo
ZHZhiguan Huang
Zhiguan Huang
YCYuhui Chen
Yuhui Chen
LZLin Zhu
Lin Zhu

26 April 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Xiaoguang LiuXiaoguang Liu
Xiaoguang Liu
MXMiaomiao Xu
Miaomiao Xu
HWHuiguo Wang
Huiguo Wang
LZLin Zhu
Lin Zhu
Acetate, propionate, and butyrate are major short-chain fatty acids (SCFAs) produced by the gut microbiota as key metabolic byproducts. These SCFAs influence skeletal muscle homeostasis and exercise performance through various mechanisms. This review explores the current knowledge on the mechanisms by which SCFAs influence muscle mass, strength, metabolism, and inflammation. Acetate enhances mitochondrial function and glucose metabolism, while butyrate supports muscle mass preservation by suppressing inflammation and autophagy. Propionate plays complex roles, aiding metabolic regulation, but potentially impairing myogenic differentiation at high concentrations. These SCFAs modulate insulin sensitivity and oxidative stress; their interactions with host energy systems and immunity significantly influence muscle health. Although their therapeutic potential is evident, further studies, especially human clinical trials, are necessary to validate their effective applications. This review synthesizes emerging evidence and outlines specific future research priorities.

20 August 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Xiaoguang LiuXiaoguang Liu
Xiaoguang Liu
MXMiaomiao Xu
Miaomiao Xu
HWHuiguo Wang
Huiguo Wang
LZLin Zhu
Lin Zhu
Obesity is a global health challenge marked by substantial inter-individual differences in responses to dietary and lifestyle interventions. Traditional weight loss strategies often overlook critical biological variations in genetics, metabolic profiles, and gut microbiota composition, contributing to poor adherence and variable outcomes. Our primary aim is to identify key biological and behavioral effectors relevant to precision medicine for weight control, with a particular focus on nutrition, while also discussing their current and potential integration into digital health platforms. Thus, this review aligns more closely with the identification of influential factors within precision medicine (e.g., genetic, metabolic, and microbiome factors) but also explores how these factors are currently integrated into digital health tools. We synthesize recent advances in nutrigenomics, nutritional metabolomics, and microbiome-informed nutrition, highlighting how tailored dietary strategies—such as high-protein, low-glycemic, polyphenol-enriched, and fiber-based diets—can be aligned with specific genetic variants (e.g., FTO and MC4R), metabolic phenotypes (e.g., insulin resistance), and gut microbiota profiles (e.g., Akkermansia muciniphila abundance, SCFA production). In parallel, digital health tools—including mobile health applications, wearable devices, and AI-supported platforms—enhance self-monitoring, adherence, and dynamic feedback in real-world settings. Mechanistic pathways such as gut–brain axis regulation, microbial fermentation, gene–diet interactions, and anti-inflammatory responses are explored to explain inter-individual differences in dietary outcomes. However, challenges such as cost, accessibility, and patient motivation remain and should be addressed to ensure the effective implementation of these integrated strategies in real-world settings. Collectively, these insights underscore the pivotal role of precision nutrition as a cornerstone for personalized, scalable, and sustainable obesity interventions.

19 June 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
HWHuan Wang
Huan Wang
WHWenbi He
Wenbi He
GYGaoyuan Yang
Gaoyuan Yang
LZLin Zhu
Lin Zhu
Xiaoguang LiuXiaoguang Liu
Xiaoguang Liu
Obesity is a systemic and chronic inflammation, which seriously endangers people’s health. People tend to diet to control weight, and the short-term effect of dieting in losing weight is significant, but the prognosis is limited. With weight loss and recovery occurring frequently, people focus on weight cycling. The effect of weight cycling on a certain tissue of the body also has different conclusions. Therefore, this article systematically reviews the effects of body weight cycling on the body and finds that multiple weight cycling (1) increased fat deposition in central areas, lean mass decreased in weight loss period, and fat mass increased in weight recovery period, which harms body composition and skeletal muscle mass; (2) enhanced the inflammatory response of adipose tissue, macrophages infiltrated into adipose tissue, and increased the production of pro-inflammatory mediators in adipocytes; (3) blood glucose concentration mutation and hyperinsulinemia caused the increase or decrease in pancreatic β-cell population, which makes β-cell fatigue and leads to β-cell failure; (4) resulted in additional burden on the cardiovascular system because of cardiovascular rick escalation. Physical activity combined with calorie restriction can effectively reduce metabolic disease and chronic inflammation, alleviating the adverse effects of weight cycling on the body.

4 September 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
WHWenbi He
Wenbi He
HWHuan Wang
Huan Wang
GYGaoyuan Yang
Gaoyuan Yang
LZLin Zhu
Lin Zhu
Xiaoguang LiuXiaoguang Liu
Xiaoguang Liu
Obesity is a global health crisis that is closely interrelated to many chronic diseases, such as cardiovascular disease and diabetes. This review provides an in-depth analysis of specific chemokines involved in the development of obesity, including C-C motif chemokine ligand 2 (CCL2), CCL3, CCL5, CCL7, C-X-C motif chemokine ligand 8 (CXCL8), CXCL9, CXCL10, CXCL14, and XCL1 (lymphotactin). These chemokines exacerbate the symptoms of obesity by either promoting the inflammatory response or by influencing metabolic pathways and recruiting immune cells. Additionally, the research highlights the positive effect of exercise on modulating chemokine expression in the obese state. Notably, it explores the potential effects of both aerobic exercises and combined aerobic and resistance training in lowering levels of inflammatory mediators, reducing insulin resistance, and improving metabolic health. These findings suggest new strategies for obesity intervention through the modulation of chemokine levels by exercise, providing fresh perspectives and directions for the treatment of obesity and future research.

9 September 2025 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
XXXianyan Xie
Xianyan Xie
YWYu Wang
Yu Wang
ZLZiyan Li
Ziyan Li
GYGaoyuan Yang
Gaoyuan Yang
GCGuodong Cheng
Guodong Cheng
LZLin Zhu
Lin Zhu
Injury and repair of the tendon-bone interface (TBI) pose a significant challenge in the fields of orthopedics and sports medicine. Due to the gradients in structure, composition, mechanical properties, and biological signals across the TBI, transitioning from flexible tendon to rigid bone, traditional surgical approaches often struggle to reconstruct its functional structure, leading to poor mechanical properties of the interface after repair and high re-tear rates. In contrast, gradient biomimetic scaffolds, by mimicking the continuous gradients of native TBI, offer an effective solution for achieving functional TBI regeneration. This review systematically summarizes the research progress of gradient biomimetic scaffolds for TBI regeneration in recent years. Firstly, we discuss the fine structure, physiological functions of native TBI, and the repair challenges faced after its injury, emphasizing the necessity of reconstructing gradient structures. Subsequently, it focuses on the design principles and core biomimetic strategies of gradient biomimetic scaffolds, discussing in depth the principles of construction and implementation strategies for physical structure gradients (e.g., porosity, fiber orientation, mechanical modulus), chemical composition gradients (e.g., degree of mineralization, polymer/ECM components), and biological signal gradients (e.g., growth factors, genes). Building upon this, this review comprehensively reviews various biomaterials for gradient scaffold construction, including natural polymers (collagen, silk fibroin, chitosan, etc.), synthetic polymers (PCL, PLGA, PU, etc.), and inorganic bioactive materials (calcium phosphate ceramics, bioactive glass), analyzing their characteristics, functionalization methods, and applications in gradient construction. Furthermore, this review also systematically summarizes and compares major fabrication techniques for gradient biomimetic scaffolds, particularly the advantages and limitations of electrospinning and additive manufacturing (3D printing) in constructing specific gradient features, and highlights emerging techniques such as microfluidics. Finally, building upon the summarized existing research findings, this review critically analyzes the key challenges and technical bottlenecks currently facing gradient biomimetic scaffolds regarding structural biomimetic accuracy, spatio-temporal control of biological functions, vascularization, and immunocompatibility, and offers perspectives on future research directions, such as smart scaffolds, integration of multiple gradients, personalized manufacturing, and clinical translation strategies.